Literature DB >> 12519087

Chemokines in the pathogenesis of liver disease: so many players with poorly defined roles.

Kenneth J Simpson1, Neil C Henderson, Cynthia L Bone-Larson, Nicholas W Lukacs, Cory M Hogaboam, Steven L Kunkel.   

Abstract

Many new chemokines have been described in recent years, resulting in a new classification of these chemoattractant proteins. The characterization of the biological functions of most chemokines relates to their ability to induce chemotaxis in circulating inflammatory cells. However, it is now clear that chemokines have a much wider biological role, including angiogenesis, carcinogenesis and involvement in the pathogenesis of HIV infection. Our understanding of the role of chemokines in the pathogenesis of disorders of the lungs and brain outstrips that with regard to disorders of the liver. An increased understanding of the role of chemokines in the pathogenesis of liver disease may lead to the development of novel therapies for hepatic disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12519087     DOI: 10.1042/

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  30 in total

1.  Nutrigenomic analysis of the protective effects of bilberry anthocyanin-rich extract in apo E-deficient mice.

Authors:  Aurelie Mauray; Catherine Felgines; Christine Morand; Andrzej Mazur; Augustin Scalbert; Dragan Milenkovic
Journal:  Genes Nutr       Date:  2010-03-01       Impact factor: 5.523

2.  Hepatic serum amyloid A1 aggravates T cell-mediated hepatitis by inducing chemokines via Toll-like receptor 2 in mice.

Authors:  Young Rae Ji; Hei Jung Kim; Ki Beom Bae; Sanggyu Lee; Myoung Ok Kim; Zae Young Ryoo
Journal:  J Biol Chem       Date:  2015-04-06       Impact factor: 5.157

Review 3.  Angiogenesis and liver fibrosis.

Authors:  Gülsüm Özlem Elpek
Journal:  World J Hepatol       Date:  2015-03-27

4.  Angiogenesis: a phenomenon which aggravates chronic liver disease progression.

Authors:  Michał Kukla
Journal:  Hepatol Int       Date:  2012-07-26       Impact factor: 6.047

5.  Gut-brain chemokine changes in portal hypertensive rats.

Authors:  Joaquin Merino; Maria-Angeles Aller; Sandra Rubio; Natalia Arias; Maria-Paz Nava; Maria Loscertales; Jaime Arias; Jorge-Luis Arias
Journal:  Dig Dis Sci       Date:  2011-02-24       Impact factor: 3.199

Review 6.  The role of chemokines in acute and chronic hepatitis C infection.

Authors:  Stephen Fahey; Eugene Dempsey; Aideen Long
Journal:  Cell Mol Immunol       Date:  2013-08-19       Impact factor: 11.530

7.  Identification, sequence characterization, and analysis of expression profiles of three novel CC chemokines from domestic duck (Anas platyrhynchos).

Authors:  E Sreekumar; Avinash Premraj; D S Arathy; T J Rasool
Journal:  Immunogenetics       Date:  2005-04-20       Impact factor: 2.846

8.  Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment.

Authors:  Judit Marsillach; Gerard Aragonès; Bharti Mackness; Michael Mackness; Anna Rull; Raúl Beltrán-Debón; Juan Pedro-Botet; Carlos Alonso-Villaverde; Jorge Joven; Jordi Camps
Journal:  Lipids Health Dis       Date:  2010-05-14       Impact factor: 3.876

9.  Angiogenesis: from chronic liver inflammation to hepatocellular carcinoma.

Authors:  Paloma Sanz-Cameno; María Trapero-Marugán; María Chaparro; Evan Anthony Jones; Ricardo Moreno-Otero
Journal:  J Oncol       Date:  2010-05-27       Impact factor: 4.375

10.  Macrophage Inflammatory Protein-3 Alpha (MIP-3α)/CCL20 in HIV-1-Infected Individuals.

Authors:  Najib Aziz; Roger Detels; L Cindy Chang; Anthony W Butch
Journal:  J AIDS Clin Res       Date:  2016-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.